Substance / Medication

Piperazine

Overview

Active Ingredient
piperazine
RxNorm CUI
8340

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
Lee HeeSeung, Wang Grace Y, Curley Louise E et al. · Psychopharmacology (Berl) · 2016
PMID: 27289365RCT
Pharmacokinetic evaluation of a newly developed piperazine dithioctate formulation in healthy volunteers.
Zheng Renhua, Song Hyung Ho, Kwon Young Ee et al. · Int J Clin Pharmacol Ther · 2014
PMID: 25345429RCT
A comparative study of the efficacy of piperazine and Carica papaya for the control of helminth parasites in village chickens in Zambia.
Chota Amos, Sikasunge Chummy Sikalizyo, Phiri Andrew M et al. · Trop Anim Health Prod · 2010
PMID: 19701804RCT
Efficacy and safety of Linkus, Aminophylline diphenhydramine and acefyllin piperazine for the treatment of cough in children.
Rehman Hina, Naveed Safila, Usmanghani Khan · Pak J Pharm Sci · 2016
PMID: 27383495Trial
Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.
Masana Lluís, Villoria Jesús, Sust Mariano et al. · Eur J Pharmacol · 2004
PMID: 15288592Trial
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium.
Byrjalsen I, Alexandersen P, Christiansen C · BJOG · 2000
PMID: 10740331Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Piperazine (substance)
SNOMED CT
428714003
UMLS CUI
C0031957
RxNorm CUI
8340

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.